Blog
RSS FeedPosted by Michael Wonder on 25 May 2021
Dupixent (dupilumab) now publicly reimbursed in Ontario and New Brunswick for the treatment of moderate to severe atopic dermatitis
25 May 2021 - Dupixent is the only biologic medicine approved by Health Canada to treat moderate to severe atopic dermatitis. ...
Posted by Michael Wonder on 20 May 2021
Budget 2021: Health boost for PHARMAC and funding for Māori Health Authority
20 May 2021 - Health Minister Andrew Little said it was one of the biggest increases PHARMAC had ever had ...
Posted by Michael Wonder on 20 May 2021
Boring Budget 2021 reinforces two tier medicines access system in New Zealand
20 May 2021 - Announcement in the budget today of $200 million over the next four years is simply meeting the ...
Posted by Michael Wonder on 20 May 2021
PHARMAC political theatre grotesque
20 May 2021 - “It is grotesque political theatre to make people wait for the budget to get their medicines ...
Posted by Michael Wonder on 18 May 2021
PHARMAC, dental funding crucial in Budget - National Party
18 May 2021 - Thursday's Budget is being promoted as a Covid-19 Recovery Budget. ...
Posted by Michael Wonder on 18 May 2021
CMS delays Medicare payments for breakthrough devices until December
17 May 2021 - Medicare coverage for FDA designated breakthrough medical devices will have to wait several more months, despite ...
Posted by Michael Wonder on 16 May 2021
Modernising Medicare coverage pathways for prescription digital therapeutics
13 May 2021 - Outpatient visit restrictions imposed in early 2020 due to COVID-19 increased demand for effective virtual health care ...
Posted by Michael Wonder on 12 May 2021
PHARMAC funding 'affects all New Zealanders'
12 May 2021 - Doubling the funding for drug-buying agency PHARMAC will save lives and allow more people to live ...
Posted by Michael Wonder on 11 May 2021
MTAA optimistic as Government rejects insurer led push to abolish Prosthesis List
11 May 2021 - The Medical Technology Association of Australia has welcomed the Government’s decision to retain the Prostheses List ...
Posted by Michael Wonder on 11 May 2021
Budget 2021–22: generational change and record investment in the health of Australians
11 May 2021 - A joint media release outlining the Morrison Government's $121.4 billion in 2021–22 and $503 billion investment into ...
Posted by Michael Wonder on 11 May 2021
Health front and centre of economic recovery
11 May 2021 - Treasurer Josh Frydenberg places the nation’s health, wellbeing and recovery from COVID-19 front and centre of ...
Posted by Michael Wonder on 06 May 2021
CMS increases Medicare payment for COVID-19 monoclonal antibody infusions
6 May 2021 - New payment policy for at-home administration. ...
Posted by Michael Wonder on 03 May 2021
PHARMAC likely to end blanket funding for kids’ cancer drugs
3 May 2021 - A woman trying to get drugs funded for young spinal muscular atrophy patients was horrified when PHARMAC ...
Posted by Michael Wonder on 29 Apr 2021
CMS should offer immediate reimbursement coverage to FDA approved breakthrough devices
29 April 2021 - In 2016 the U.S. Congress passed, and President Barack Obama signed, the 21st Century Cures Act. Section ...
Posted by Michael Wonder on 29 Apr 2021
Valeo Pharma’s Redesca and Redesca HP to be covered under the Ontario Public Drug Benefit Program
28 April 2021 - Additional provincial coverage expected to follow. ...